Long-Term Assets: The sum of all assets classified as non-current.
Syndax Pharmaceuticals, Inc. (SNDX) had Long-Term Assets of $121.76M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$23.68M |
|
$-318.76M |
|
$0.83M |
|
$22.85M |
|
$363.35M |
|
$-339.67M |
|
$20.91M |
|
$-318.76M |
|
$-318.76M |
|
$-318.76M |
|
$-318.76M |
|
$-318.76M |
|
$-318.76M |
|
$-339.67M |
|
$-353.10M |
|
85.62M |
|
85.62M |
|
$-3.72 |
|
$-3.72 |
|
| Balance Sheet Financials | |
$603.06M |
|
-- |
|
|
Long-Term Assets |
$121.76M |
$724.82M |
|
$103.55M |
|
$331.56M |
|
$333.14M |
|
$436.69M |
|
$288.12M |
|
$288.12M |
|
$288.12M |
|
85.69M |
|
| Cash Flow Statement Financials | |
$-274.90M |
|
$-219.78M |
|
$353.37M |
|
$295.61M |
|
$154.30M |
|
$-141.31M |
|
$43.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.82 |
|
-- |
|
-- |
|
0.54 |
|
1.19 |
|
96.51% |
|
-1434.43% |
|
-1434.43% |
|
-1491.14% |
|
-1346.11% |
|
-1346.11% |
|
$-274.90M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
2.26 |
|
2.11 |
|
173.21 |
|
-110.63% |
|
-110.63% |
|
-43.98% |
|
-51.44% |
|
$3.36 |
|
$-3.21 |
|
$-3.21 |
|